Your browser is no longer supported. Please, upgrade your browser.
Settings
HBIO Harvard Bioscience, Inc. daily Stock Chart
HBIO [NASD]
Harvard Bioscience, Inc.
Index- P/E- EPS (ttm)-0.17 Insider Own8.40% Shs Outstand38.92M Perf Week-5.50%
Market Cap152.79M Forward P/E14.00 EPS next Y0.27 Insider Trans0.59% Shs Float34.01M Perf Month20.77%
Income-6.60M PEG- EPS next Q0.07 Inst Own74.90% Short Float3.80% Perf Quarter11.50%
Sales102.10M P/S1.50 EPS this Y-5.10% Inst Trans0.96% Short Ratio10.65 Perf Half Y43.18%
Book/sh1.98 P/B1.91 EPS next Y71.97% ROA-4.30% Target Price5.33 Perf Year29.01%
Cash/sh0.07 P/C54.57 EPS next 5Y10.00% ROE-8.50% 52W Range1.39 - 4.41 Perf YTD23.93%
Dividend- P/FCF20.10 EPS past 5Y-30.30% ROI0.90% 52W High-14.19% Beta1.72
Dividend %- Quick Ratio1.00 Sales past 5Y1.30% Gross Margin56.40% 52W Low171.94% ATR0.22
Employees505 Current Ratio2.00 Sales Q/Q-12.40% Oper. Margin-0.90% RSI (14)57.51 Volatility6.76% 6.29%
OptionableYes Debt/Eq0.56 EPS Q/Q59.00% Profit Margin-6.50% Rel Volume0.41 Prev Close3.68
ShortableYes LT Debt/Eq0.53 EarningsNov 05 BMO Payout- Avg Volume121.31K Price3.78
Recom1.70 SMA200.93% SMA5011.97% SMA20025.27% Volume50,173 Change2.72%
Nov-10-20Initiated KeyBanc Capital Markets Overweight $6
Jul-08-19Downgrade Janney Buy → Neutral $2
Jan-24-18Reiterated Janney Buy $5 → $8
Jan-23-18Reiterated The Benchmark Company Buy $6 → $10
Nov-17-16Initiated Singular Research Buy $5.50
Jul-28-15Initiated The Benchmark Company Buy $8
Nov-16-20 04:35PM  
Nov-10-20 08:40AM  
Nov-05-20 07:00AM  
06:15AM  
Oct-20-20 04:45PM  
Oct-05-20 09:57AM  
Sep-16-20 04:30PM  
Aug-06-20 11:01AM  
Aug-05-20 07:00AM  
Jul-20-20 08:30AM  
Jul-05-20 04:30PM  
Jun-26-20 10:12PM  
Jun-12-20 04:43PM  
May-26-20 05:15PM  
May-05-20 09:15AM  
07:00AM  
May-01-20 10:11AM  
Apr-28-20 12:33PM  
Apr-23-20 07:01PM  
04:25PM  
Apr-16-20 07:06AM  
Apr-06-20 04:39PM  
Mar-23-20 09:00AM  
Mar-06-20 09:57AM  
Feb-28-20 07:48AM  
Feb-26-20 09:36AM  
07:15AM  
06:00AM  
Feb-21-20 06:16PM  
Feb-20-20 07:55AM  
Feb-11-20 05:15PM  
Jan-15-20 07:00AM  
Dec-30-19 08:29AM  
Dec-18-19 07:52AM  
Dec-13-19 03:45PM  
Dec-10-19 08:56AM  
Nov-29-19 06:33AM  
Nov-21-19 04:45PM  
Nov-19-19 10:20AM  
Nov-05-19 06:15PM  
04:00PM  
Nov-04-19 09:28AM  
Nov-01-19 08:15AM  
Oct-31-19 05:10PM  
Oct-29-19 10:33AM  
Oct-22-19 06:31PM  
Oct-21-19 08:45AM  
Oct-17-19 10:34AM  
Oct-07-19 01:40PM  
Sep-10-19 08:52AM  
Sep-09-19 08:00AM  
Sep-04-19 04:45PM  
04:45PM  
Aug-15-19 07:35AM  
Aug-05-19 05:43PM  
Jul-26-19 07:26AM  
Jul-25-19 06:25PM  
04:00PM  
02:30PM  
Jul-19-19 04:45PM  
02:31PM  
02:04PM  
Jul-18-19 05:44PM  
10:33AM  
Jul-17-19 09:15AM  
Jul-09-19 07:11AM  
Jul-08-19 07:48AM  
Jun-28-19 05:45PM  
Jun-26-19 04:10PM  
Jun-17-19 09:46AM  
May-22-19 08:24AM  
May-15-19 05:00PM  
May-09-19 09:32AM  
May-02-19 07:05PM  
06:02PM  
04:01PM  
Apr-26-19 09:23AM  
Apr-25-19 10:34AM  
Apr-24-19 10:33AM  
Apr-23-19 05:25PM  
Apr-03-19 05:18PM  
02:51PM  
Mar-26-19 05:15PM  
Mar-19-19 04:27PM  
Feb-28-19 04:02PM  
02:30PM  
Feb-26-19 04:30PM  
Feb-19-19 04:05PM  
Feb-08-19 11:40AM  
Jan-09-19 08:17AM  
Dec-14-18 06:35AM  
Nov-23-18 07:25AM  
Nov-21-18 11:04AM  
Nov-02-18 02:30PM  
Oct-31-18 12:04AM  
Oct-25-18 07:00PM  
05:55PM  
04:02PM  
Oct-23-18 08:35AM  
Oct-22-18 04:11PM  
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue, organ, and animal based lab research; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. The company also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems for use with custom amplifier configurations, vivo-systems solution for in vivo recordings with microelectrode arrays, and vitro-systems for extracellular recordings from microelectrode arrays in vitro; and offers preclinical products, systems, services, and solutions with a focus on physiologic monitoring solutions. It markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. The company primarily sells its products under Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, Hugo Sachs Elektronik, Scie-Plas, BTX, Multi Channel Systems, HEKA, DSI, Ponemah, and Buxco brand names in North America, Europe, and internationally. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EDRICK ALAN IDirectorJun 12Buy2.6320,00052,50067,500Jun 16 06:00 PM
Green James WChief Executive OfficerMay 07Buy2.5310,00025,3001,512,445May 08 04:49 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.